Alyssum Therapeutics announces Nature Nanotechnology publication on first B cell-activating drug to treat solid tumors
Recruitment of B cells to tumors is shown to result in long-term survival in multiple types of cancer CAMBRIDGE, MA, UNITED STATES, June 29, 2026 /EINPresswire.com/ -- Alyssum Therapeutics, a clinical-stage biopharmaceutical company pioneering …